Esomeprazole has not been linked to birth defects in the available research, but it’s not the first-choice acid reflux medication during pregnancy. The data on its use in pregnant women is more limited than for its close relative omeprazole, so most guidelines recommend trying other options first and reserving esomeprazole (or any proton pump inhibitor) for cases where milder treatments haven’t worked.
What the Safety Data Shows
The European Medicines Agency reviewed pregnancy outcomes for esomeprazole and found a 1.7% rate of congenital malformations among exposed pregnancies, which falls well within the general background rate of roughly 2.8% seen in all pregnancies. That review covered between 300 and 1,000 pregnancy outcomes, enough to provide moderate reassurance but not the large-scale data that exists for older medications like omeprazole.
A large study published in JAMA Network Open took the analysis further by comparing siblings within the same family, where one pregnancy involved early PPI use and one did not. This design helps control for genetic and environmental factors that run in families. The results showed no meaningful increase in risk: the adjusted odds ratio was 1.05 for major congenital malformations and 1.07 for congenital heart defects, both statistically indistinguishable from no effect at all.
In practical terms, these numbers mean that first-trimester exposure to a proton pump inhibitor like esomeprazole does not appear to raise the chance of birth defects above what any pregnancy carries as baseline risk.
Why Omeprazole Is Often Recommended Instead
Esomeprazole is essentially the active half of omeprazole. The two drugs work almost identically, but omeprazole has been available much longer and has been studied in far more pregnancies. The NHS specifically notes that doctors may suggest omeprazole over esomeprazole simply because there is more safety information available for it. This isn’t because esomeprazole has shown problems. It’s a practical preference for the drug with the bigger evidence base.
If you’re already taking esomeprazole and discover you’re pregnant, this distinction matters less than it might seem. The existing data on esomeprazole is reassuring, and your doctor can help you decide whether switching medications makes sense for your situation.
The Step-Up Approach to Reflux in Pregnancy
Heartburn and acid reflux affect the majority of pregnant women, especially in the second and third trimesters, as the growing uterus pushes stomach contents upward and pregnancy hormones relax the valve between the stomach and esophagus. Treatment guidelines follow a step-up approach, starting with the gentlest options and escalating only when needed.
The first step is lifestyle changes: eating smaller meals, avoiding food within a few hours of lying down, elevating the head of your bed, and steering clear of trigger foods like citrus, chocolate, and spicy dishes. When that’s not enough, calcium-containing antacids are the preferred first medication. If antacids alone don’t control symptoms, sucralfate (a coating agent that protects the stomach lining) can be added.
The next tier is an H2 blocker, a class of drugs that reduces acid production more effectively than antacids. Only when all of these options fail to provide adequate relief do guidelines recommend stepping up to a proton pump inhibitor like esomeprazole or omeprazole, typically alongside antacids for breakthrough symptoms. This cautious sequencing isn’t unique to pregnancy. It reflects the general principle of using the least intervention necessary.
Safety During Breastfeeding
Esomeprazole passes into breast milk in very small amounts. At a maternal dose of 10 mg daily, the highest measured milk concentration translated to about 1.8% of the mother’s weight-adjusted dose reaching the infant. By 8 to 10 hours after a dose, the drug was undetectable in milk samples. In the limited case reports available, breastfed infants whose mothers took esomeprazole showed no drug-related adverse effects.
One case study tracked an infant who was about half breastfed and half formula-fed while the mother took 10 mg of esomeprazole daily. Esomeprazole was detected in cord blood at birth (from placental passage) but was undetectable in the infant’s blood by about 23 hours later, reflecting how quickly the drug is cleared. The infant developed normally with no apparent side effects.
What This Means in Practice
If you’re pregnant and dealing with severe heartburn that isn’t responding to antacids or H2 blockers, proton pump inhibitors remain a reasonable option. The current evidence does not show that esomeprazole increases the risk of birth defects or other pregnancy complications. The main reason it carries a “not recommended” label for pregnancy is the relatively limited number of studied exposures compared to omeprazole, not any signal of harm.
For most pregnant women, the practical path is to try lifestyle changes and antacids first, move to an H2 blocker if needed, and discuss a proton pump inhibitor with your provider if reflux remains uncontrolled. If a PPI is warranted, your doctor may lean toward omeprazole based on its longer track record, though esomeprazole’s available safety profile is similarly reassuring.